Author: Arghavan Jahandideh

Max Miner defends his dissertation entitled “Emerging Radiopharmacetuicals for PET-imaging Gliomas” at the University of Turku on 29 August 2023 at 12.00 pm (TYKS T Hospital, Risto Lahesmaa auditorium, Hämeentie 11, 20520 Turku).

The audience can participate in the defence by remote access: https://utu.zoom.us/j/62033783502

Opponent: Professor Klaus Kopka (Helmholtz-Zentrum Dresden-Rossendorf Research Centre, Germany)
Custos: Professor Anne Roivainen (University of Turku)

Olli will defend his thesis titled ” Development of radiopharmaceuticals for PET imaging of inflammation and cancer “.

The first VAP-1 targeted PET tracer [68Ga]Ga-DOTA-Siglec-9 has finally entered in clinical trials. Sofar, two healthy volunteers have successfully been imaged at Turku PET Centre. (ClinicalTrials.gov Identifier: NCT03755245: Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis (SIGLEC))